ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $603,000 | -58.0% | 295,423 | -40.9% | 0.00% | – |
| Q3 2019 | $1,435,000 | -80.1% | 500,109 | -46.9% | 0.00% | -100.0% |
| Q2 2019 | $7,225,000 | -42.3% | 941,976 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $12,520,000 | -14.7% | 941,976 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $14,675,000 | -20.7% | 941,976 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $18,510,000 | -31.5% | 941,976 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $27,035,000 | +21.4% | 941,976 | 0.0% | 0.01% | +12.5% |
| Q1 2018 | $22,278,000 | +7.3% | 941,976 | -2.7% | 0.01% | +14.3% |
| Q4 2017 | $20,759,000 | +56.6% | 967,798 | +72.7% | 0.01% | +40.0% |
| Q3 2017 | $13,252,000 | +20.0% | 560,350 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $11,039,000 | +6.2% | 560,350 | +13.3% | 0.00% | 0.0% |
| Q1 2017 | $10,390,000 | +27.8% | 494,766 | +14.4% | 0.00% | 0.0% |
| Q4 2016 | $8,128,000 | +11.3% | 432,363 | +18.1% | 0.00% | +33.3% |
| Q3 2016 | $7,300,000 | -15.0% | 366,073 | +8.7% | 0.00% | -25.0% |
| Q2 2016 | $8,592,000 | -3.6% | 336,873 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,910,000 | -38.2% | 336,873 | 0.0% | 0.00% | -42.9% |
| Q4 2015 | $14,411,000 | +61.4% | 336,873 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $8,931,000 | -20.5% | 336,873 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $11,228,000 | -12.1% | 336,873 | -12.2% | 0.01% | 0.0% |
| Q1 2015 | $12,774,000 | -22.6% | 383,828 | -5.0% | 0.01% | -25.0% |
| Q4 2014 | $16,506,000 | +30.5% | 403,872 | +8.2% | 0.01% | +14.3% |
| Q3 2014 | $12,649,000 | -49.7% | 373,356 | -50.0% | 0.01% | 0.0% |
| Q2 2014 | $25,172,000 | +96.8% | 746,712 | +121.3% | 0.01% | 0.0% |
| Q1 2014 | $12,793,000 | +29.8% | 337,452 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $9,854,000 | -14.8% | 337,452 | 0.0% | 0.01% | -14.3% |
| Q3 2013 | $11,567,000 | +20.3% | 337,452 | +15.7% | 0.01% | +16.7% |
| Q2 2013 | $9,619,000 | +98.6% | 291,570 | +92.8% | 0.01% | +100.0% |
| Q1 2013 | $4,844,000 | +0.9% | 151,231 | -19.3% | 0.00% | 0.0% |
| Q3 2012 | $4,801,000 | +6.4% | 187,487 | 0.0% | 0.00% | -25.0% |
| Q2 2012 | $4,513,000 | – | 187,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |